site logo

Novavax says vaccine 90% effective against COVID-19 in large trial

Highly anticipated results from a Phase 3 study testing the biotech company's shot showed it to be strongly protective and safe, a potential boon for the world's vaccination efforts.

Courtesy of Novavax